CXS chemgenex pharmaceuticals ltd

poster data from ash, page-3

  1. 21 Posts.
    Scarey isnt it!
    And considering that oncology treatments will be needeed regardless of the surrounding economic situation. Looks like we have a brief opportunity to accumulate before final results come in. EG Capital has a new price target of $1.80.

    AVX may also be one to keep an eye on in the area of HIV. Another resistance story in a chronic life long treatment area.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.